Using pre-validated sandwich ELISA assays (Supplementary Figure 3A), we tested GALNT7 protein levels in urine and blood samples from men with suspected prostate cancer (our power calculations showed testing at least 20 samples would give us a 90% chance of detecting any significant changes, p < 0.05). The gene discussed is GALNT7; the disease is prostate carcinoma.